• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Early lymphocyte recovery in Ewing sarcoma.

作者信息

DuBois Steven G, Elterman Kelly, Grier Holcombe E

出版信息

J Pediatr Hematol Oncol. 2007 May;29(5):351-2. doi: 10.1097/MPH.0b013e3180590627.

DOI:10.1097/MPH.0b013e3180590627
PMID:17483722
Abstract
摘要

相似文献

1
Early lymphocyte recovery in Ewing sarcoma.尤因肉瘤中淋巴细胞的早期恢复
J Pediatr Hematol Oncol. 2007 May;29(5):351-2. doi: 10.1097/MPH.0b013e3180590627.
2
Time to diagnosis of Ewing tumors in children and adolescents is not associated with metastasis or survival: a prospective multicenter study of 436 patients.儿童和青少年尤文氏瘤的诊断时间与转移或生存无关：436 例患者的前瞻性多中心研究。
J Clin Oncol. 2014 Jun 20;32(18):1935-40. doi: 10.1200/JCO.2013.53.8058. Epub 2014 May 19.
3
Atypical extraosseous Ewing sarcoma of the spinal canal with bone marrow involvement in a two-month-old boy.一名两个月大男童发生的累及骨髓的椎管非典型骨外尤因肉瘤。
Med Pediatr Oncol. 1999 Jun;32(6):471-3. doi: 10.1002/(sici)1096-911x(199906)32:6<471::aid-mpo22>3.0.co;2-y.
4
Carboplatin in the treatment of Ewing sarcoma: Results of the first Brazilian collaborative study group for Ewing sarcoma family tumors-EWING1.卡铂治疗尤因肉瘤：巴西首个尤因肉瘤家族性肿瘤协作研究组-EWING1的研究结果
Pediatr Blood Cancer. 2015 Oct;62(10):1747-53. doi: 10.1002/pbc.25562. Epub 2015 Apr 27.
5
Primary cutaneous and subcutaneous Ewing sarcoma.原发性皮肤和皮下尤因肉瘤。
Pediatr Blood Cancer. 2015 Sep;62(9):1555-61. doi: 10.1002/pbc.25535. Epub 2015 Apr 20.
6
Ewing Sarcoma: A 15-Year Experience of a Single Center With the MSKCC P6 Treatment Protocol.
J Pediatr Hematol Oncol. 2016 Jan;38(1):38-42. doi: 10.1097/MPH.0000000000000456.
7
Prognostic factors and patterns of relapse in ewing sarcoma patients treated with chemotherapy and r0 resection.接受化疗和R0切除治疗的尤因肉瘤患者的预后因素及复发模式
Int J Radiat Oncol Biol Phys. 2015 Jun 1;92(2):349-57. doi: 10.1016/j.ijrobp.2015.01.022. Epub 2015 Mar 12.
8
Ewing sarcoma: prognostic criteria, outcomes and future treatment.尤因肉瘤：预后标准、治疗结果及未来治疗
Expert Rev Anticancer Ther. 2008 Apr;8(4):617-24. doi: 10.1586/14737140.8.4.617.
9
Good outcome for infant of mother treated with chemotherapy for ewing sarcoma at 25 to 30 weeks' gestation.妊娠25至30周时接受化疗的尤文肉瘤母亲所生婴儿预后良好。
J Pediatr Hematol Oncol. 2004 May;26(5):308-11. doi: 10.1097/00043426-200405000-00010.
10
Ewing sarcoma of the clavicle in a 10-month-old patient.一名10个月大患者的锁骨尤文肉瘤。
Med Pediatr Oncol. 2000 Jun;34(6):445-7. doi: 10.1002/(sici)1096-911x(200006)34:6<445::aid-mpo14>3.0.co;2-k.

引用本文的文献

1
Neutrophil to lymphocyte ratio (NTLR) predicts local control and overall survival after stereotactic body radiotherapy (SBRT) in metastatic sarcoma.中性粒细胞与淋巴细胞比值（NTLR）预测转移性肉瘤立体定向体部放疗（SBRT）后的局部控制和总生存。
Sci Rep. 2023 Nov 7;13(1):19256. doi: 10.1038/s41598-023-46476-3.
2
Immature platelet fraction predicts early marrow recovery after severe chemotherapy associated neutropenia.血小板幼稚分数可预测严重化疗相关性中性粒细胞减少后早期骨髓恢复。
Sci Rep. 2023 Feb 27;13(1):3371. doi: 10.1038/s41598-023-30469-3.
3
Prospective Trial of Neutrophil/Lymphocyte Ratio and Other Blood Counts as Biomarkers of Survival among Patients with High-Grade Soft Tissue Sarcomas Treated with Pegylated Liposomal Doxorubicin and Ifosfamide.
中性粒细胞/淋巴细胞比值及其他血细胞计数作为接受聚乙二醇化脂质体阿霉素和异环磷酰胺治疗的高级别软组织肉瘤患者生存生物标志物的前瞻性试验
Cancers (Basel). 2022 Jul 14;14(14):3419. doi: 10.3390/cancers14143419.
4
Glutamine for Amelioration of Radiation and Chemotherapy Associated Mucositis during Cancer Therapy.谷氨酰胺改善癌症治疗中放化疗相关性黏膜炎。
Nutrients. 2020 Jun 4;12(6):1675. doi: 10.3390/nu12061675.
5
Lymphocyte-monocyte ratio at day 14 of first cisplatin-doxorubicin chemotherapy is associated with treatment outcome of pediatric patients with localized osteosarcoma.顺铂-阿霉素首次化疗第14天时的淋巴细胞-单核细胞比值与局限性骨肉瘤患儿的治疗结果相关。
Korean J Pediatr. 2019 Feb;62(2):62-67. doi: 10.3345/kjp.2018.06618. Epub 2018 Oct 1.
6
Immune Therapy for Sarcomas.肉瘤的免疫治疗
Adv Exp Med Biol. 2017;995:127-140. doi: 10.1007/978-3-319-53156-4_6.
7
A phase II study of clinical activity of SCH 717454 (robatumumab) in patients with relapsed osteosarcoma and Ewing sarcoma.SCH 717454（robatumumab）用于复发骨肉瘤和尤因肉瘤患者的临床活性II期研究。
Pediatr Blood Cancer. 2016 Oct;63(10):1761-70. doi: 10.1002/pbc.26087. Epub 2016 Jun 30.
8
Adjuvant Immunotherapy to Improve Outcome in High-Risk Pediatric Sarcomas.辅助免疫疗法改善高危儿童肉瘤的预后
Clin Cancer Res. 2016 Jul 1;22(13):3182-91. doi: 10.1158/1078-0432.CCR-15-2550. Epub 2016 Jan 28.
9
Absolute lymphocyte counts refine minimal residual disease-based risk stratification in childhood acute lymphoblastic leukemia.绝对淋巴细胞计数可细化儿童急性淋巴细胞白血病基于微小残留病的危险分层。
Pediatr Blood Cancer. 2012 Sep;59(3):468-74. doi: 10.1002/pbc.23395. Epub 2011 Nov 18.
10
Murine rhabdomyosarcoma is immunogenic and responsive to T-cell-based immunotherapy.鼠横纹肌肉瘤具有免疫原性，并对基于 T 细胞的免疫疗法有反应。
Pediatr Blood Cancer. 2011 Dec 1;57(6):921-9. doi: 10.1002/pbc.23048. Epub 2011 Apr 1.